trending Market Intelligence /marketintelligence/en/news-insights/trending/yWImQNIjCRSURPrBH1FOlQ2 content esgSubNav
In This List

Fennec Pharmaceuticals plans common stock offering

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Fennec Pharmaceuticals plans common stock offering

Fennec Pharmaceuticals Inc. plans to offer its common shares in an underwritten public offering.

The biotechnology company also plans to grant the underwriters an option to buy up to an additional 15% of the common shares offered.

Wedbush PacGrow is acting as the sole book-running manager for the proposed offering, while H.C. Wainwright & Co. is acting as the co-manager.